Efficacy and safety of radiofrequency ablation of Barrett’s esophagus in the absence of reimbursement: a multicenter prospective Belgian registry | Zendy

Joke Vliebergh | Zendy; Pierre H. Deprez | Zendy; Danny De Looze | Zendy; Marc Ferrante | Zendy; Hans Orlent | Zendy; Elisabeth Macken | Zendy; Paul Christiaens | Zendy; Fazia Mana | Zendy; Gert De Hertogh | Zendy; Hilde Willekens | Zendy; Raf Bisschops | Zendy

Open Access

Efficacy and safety of radiofrequency ablation of Barrett’s esophagus in the absence of reimbursement: a multicenter prospective Belgian registry

Author(s) -

Joke Vliebergh,

Pierre H. Deprez,

Danny De Looze,

Marc Ferrante,

Hans Orlent,

Elisabeth Macken,

Paul Christiaens,

Fazia Mana,

Gert De Hertogh,

Hilde Willekens,

Raf Bisschops

Publication year - 2018

Publication title -

endoscopy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.78

H-Index - 143

eISSN - 1438-8812

pISSN - 0013-726X

DOI - 10.1055/a-0739-7679

Subject(s) - medicine , reimbursement , multicenter study , esophagus , general surgery , radiofrequency ablation , prospective cohort study , ablation , barrett's esophagus , surgery , adenocarcinoma , randomized controlled trial , health care , cancer , economics , economic growth

Radiofrequency ablation (RFA), combined with endoscopic resection, can be used as a primary treatment for low grade dysplasia, high grade dysplasia, and early esophageal adenocarcinoma (EAC) in Barrett's esophagus (BE). The aim of the Belgian RFA registry is to capture the real-life outcome of endoscopic therapy for BE with RFA and to assess efficacy and safety outside study protocols, in the absence of reimbursement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research